Ethyl [1,2,3]triazolo[1,5-a]pyridine-3-carboxylate, 1g

2-(5-methyl-4H-1,2,4-triazol-3-yl)acetonitrile, 98%, 250mg

4,4'-Dimethylbenzhydrol>98.0%(GC)1g

ethyl 4-(4-cyanophenyl)-2-hydroxy-4-oxobut-2-enoate, 97%, 50mg

2-(Benzyloxy)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 95+%, 1g

(E)-N-(2-Chloro-6-methylphenyl)-3-ethoxyacrylamide, 95.0%, 10g

2-amino-N-((3-benzyl-1,2,4-oxadiazol-5-yl)methyl)acetamide hydrochloride, 95.0%, 250mg

4'-Chloro-3'-fluorobutyrophenone, 97.0%, 1g

4-Bromo-5-(trifluoromethyl)pyridin-2-amine, 97%, 1g

Trityl Bromide>98.0%(T)25g

Methyl 5-chlorofuran-2-carboxylate, 95.0%, 1g

Anti-GD1b Monoclonal Antibody1vial

(R)-1-(3-Bromo-2-methylphenyl)ethanamine hydrochloride, 1g